Switching to amisulpride monotherapy for treatment-resistant schizophrenia.

Authors :: Kontaxakis VP
Havaki-Kontaxaki BJ
Ferentinos PP
Paplos KG
Soldatos CR
Source :: European psychiatry : the journal of the Association of European Psychiatrists [Eur Psychiatry] 2006 Apr; Vol. 21 (3), pp. 214-7. Date of Electronic Publication: 2006 Mar 13.
Publication Year :: 2006
Abstract: The objective of this study was to assess switching to amisulpride (AMS) in treatment-resistant schizophrenia. Seven male subjects were switched to AMS and followed for 8 weeks. PANSS scores improved from 123 to 66 over this period. We conclude that AMS is of interest in the treatment of refractory schizophrenia.

Subjects :: Adult
Amisulpride
Antipsychotic Agents adverse effects
Follow-Up Studies
Humans
Male
Psychiatric Status Rating Scales
Schizophrenic Psychology
Sulpiride adverse effects
Sulpiride therapeutic use
Treatment Outcome
Antipsychotic Agents therapeutic use
Drug Resistance
Schizophrenia drug therapy
Sulpiride analogs & derivatives

Language :: English
ISSN :: 0924-9338
Volume :: 21
Issue :: 3
Database :: MEDLINE
Journal :: European psychiatry : the journal of the Association of European Psychiatrists
Publication Type :: Academic Journal
Accession number :: 16531015
Full Text :: https://doi.org/10.1016/j.eurpsy.2006.01.013